Cite
HARVARD Citation
Otter, S. et al. (2019). The Role of Biomarkers for the Prediction of Response to Checkpoint Immunotherapy and the Rationale for the Use of Checkpoint Immunotherapy in Cervical Cancer. Clinical oncology. 31 (12), pp. 834-843. [Online].